Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists and other physicians.
| NASDAQ: SNTS |
| Current Price: 4.75 |
| Change: 0.00 |
3/18/2010 4:01:00 AM EST
Quotes delayed 20 minutes.
|
|
3/3/2010
Santarus Reports Fourth Quarter and Full Year 2009 Financial Results
2/25/2010
Santarus to Present at March Investment Conferences
2/17/2010
Santarus to Hold Fourth Quarter and Full Year 2009 Financial Results Conference Call on March 3
|
Santarus is hiring skilled people like you. Join our team today!
